BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22154766)

  • 1. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns.
    Vanky E; Carlsen SM
    Fertil Steril; 2012 Feb; 97(2):509-15. PubMed ID: 22154766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.
    Carlsen SM; Vanky E
    Hum Reprod; 2010 Mar; 25(3):786-90. PubMed ID: 20023292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.
    Carlsen SM; Vanky E; Fleming R
    Hum Reprod; 2009 Jul; 24(7):1732-8. PubMed ID: 19342396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL
    Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
    Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
    Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
    Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
    Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
    Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
    Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM
    Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin.
    Tomova A; Deepinder F; Robeva R; Kirilov G; Mechandjiev Z; Kumanov P
    Horm Metab Res; 2011 Sep; 43(10):723-7. PubMed ID: 21932178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
    J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
    Hero M; Tommiska J; Vaaralahti K; Laitinen EM; Sipilä I; Puhakka L; Dunkel L; Raivio T
    Fertil Steril; 2012 May; 97(5):1242-7. PubMed ID: 22405597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
    Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
    Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.
    Fábregues F; Castelo-Branco C; Carmona F; Guimerá M; Casamitjana R; Balasch J
    Gynecol Endocrinol; 2011 Apr; 27(4):216-24. PubMed ID: 20500102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
    Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.